ONE MAN CAN AND WILL FIND A WAY,

WHY NOT BE THAT MAN...
Prof Dr Piet Hein van der Graaf

Prof Dr Piet Hein van der Graaf

Pharmacologist

In 1990 Piet Hein van der Graaf completed the Pharmaceutical programme at the University of Groningen. In the year thereafter he also completed his apothecary examme.He was PhD student of the Nobel-prize winning Sir Jamer Black at the Kings College School of Medicine and Dentistry in Londen (UK) in 1994. After postdocs at the Erasmus University of Rotterdam and the Synthelabo Recherche in Paris he was Royal Netherlands Academy of Arts and Sciences (KNAW) researcher at the LACDR from 1996 until 2000.Van der Graaf developed PK-PD models in the team of professor Breimer and professor Danhof. Subsequently he left for Sandwich (UK) were he built his career at Pfizer Global Research & Development. In 2010 he was appointed as Senior Director Pharmacometrics and Global Clinical Pharmacology.Van der Graaf is an international expert in the quantitative pharmacology and also one of the pioneers in the PKPD modeling, with over 75 scientific articles and target discovery patents on his name.Recently he was appointed Fellow of the British Pharmacological Society and Chief Editor of CPT Pharmacometrics & Systems Pharmacology (www.nature.com/psp). Piet Hein van der Graaf is married and father to three daughters.

Prof. Dr. Leonard van den Berg

Prof. Dr. Leonard van den Berg

Neurologist

Professor Leonard van den Berg has joined the Scientific Advisory Board since January 2014.

He has been professor of Experimental Neurology at Utrecht University since 2005 and leads a research group focused on translational research into ALS and other diseases of motor neurons. His research has been focused on the search for effective treatment for patients with motor neuron diseases (MND) and motor neuropathies by delineating the biological and molecular pathways that initiate and/or drive motor neuron degeneration.

He is principal investigator of the largest, prospective population-based case-control study in ALS (PAN). He is founder and director of The Netherlands ALS Center, which aims to improve the diagnosis, treatment/care and scientific research for ALS in the Netherlands. He promotes international collaborations on ALS research as chairman of the European Network to find the Cure for ALS (ENCALS)) and as coordinator of awarded EU grants (FP7 Euro-MOTOR (systems biology), JPND SOPHIA (biomarkers)). Professor van den Berg has a PhD from Utrecht University.